Literature DB >> 31610076

Characterization of a Citrulline 4-Hydroxylase from Nonribosomal Peptide GE81112 Biosynthesis and Engineering of Its Substrate Specificity for the Chemoenzymatic Synthesis of Enduracididine.

Christian R Zwick1, Max B Sosa1, Hans Renata1.   

Abstract

The GE81112 tetrapeptides are a small family of unusual nonribosomal peptide congeners with potent inhibitory activity against prokaryotic translation initiation. With the exception of the 3-hydroxy-l-pipecolic acid unit, little is known about the biosynthetic origins of the non-proteinogenic amino acid monomers of the natural product family. Here, we elucidate the biogenesis of the 4-hydroxy-l-citrulline unit and establish the role of an iron- and α-ketoglutarate-dependent enzyme (Fe/αKG) in the pathway. Homology modelling and sequence alignment analysis further facilitate the rational engineering of this enzyme to become a specific 4-arginine hydroxylase. We subsequently demonstrate the utility of this engineered enzyme in the synthesis of a dipeptide fragment of the antibiotic enduracidin. This work highlights the value of applying a bioinformatics-guided approach in the discovery of novel enzymes and engineering of new catalytic activity into existing ones.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biocatalysis; biosynthesis; citrulline hydroxylase; enzyme engineering; non-heme dioxygenases

Mesh:

Substances:

Year:  2019        PMID: 31610076      PMCID: PMC6917913          DOI: 10.1002/anie.201910659

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  35 in total

1.  Argimicins B and C, new anti-cyanobacterial compounds produced by Sphingomonas sp. M-17.

Authors:  Takashi Yamaguchi; Yoshie Kobayashi; Kyoko Adachi; Nobutaka Imamura
Journal:  J Antibiot (Tokyo)       Date:  2003-07       Impact factor: 2.649

2.  VioC is a non-heme iron, alpha-ketoglutarate-dependent oxygenase that catalyzes the formation of 3S-hydroxy-L-arginine during viomycin biosynthesis.

Authors:  Xihou Yin; T Mark Zabriskie
Journal:  Chembiochem       Date:  2004-09-06       Impact factor: 3.164

3.  Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic.

Authors:  Letizia Brandi; Attilio Fabbretti; Anna La Teana; Monica Abbondi; Daniele Losi; Stefano Donadio; Claudio O Gualerzi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-27       Impact factor: 11.205

4.  Two Distinct Mechanisms for C-C Desaturation by Iron(II)- and 2-(Oxo)glutarate-Dependent Oxygenases: Importance of α-Heteroatom Assistance.

Authors:  Noah P Dunham; Wei-Chen Chang; Andrew J Mitchell; Ryan J Martinie; Bo Zhang; Jonathan A Bergman; Lauren J Rajakovich; Bo Wang; Alexey Silakov; Carsten Krebs; Amie K Boal; J Martin Bollinger
Journal:  J Am Chem Soc       Date:  2018-06-04       Impact factor: 15.419

Review 5.  Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating protein sequence similarity networks.

Authors:  John A Gerlt; Jason T Bouvier; Daniel B Davidson; Heidi J Imker; Boris Sadkhin; David R Slater; Katie L Whalen
Journal:  Biochim Biophys Acta       Date:  2015-04-18

6.  Solution-phase total synthesis of teixobactin.

Authors:  Bowen Gao; Sigui Chen; Yun Nan Hou; Yong Juan Zhao; Tao Ye; Zhengshuang Xu
Journal:  Org Biomol Chem       Date:  2019-01-31       Impact factor: 3.876

7.  Inhibition of translation initiation complex formation by GE81112 unravels a 16S rRNA structural switch involved in P-site decoding.

Authors:  Attilio Fabbretti; Andreas Schedlbauer; Letizia Brandi; Tatsuya Kaminishi; Anna Maria Giuliodori; Raffaella Garofalo; Borja Ochoa-Lizarralde; Chie Takemoto; Shigeyuki Yokoyama; Sean R Connell; Claudio O Gualerzi; Paola Fucini
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-06       Impact factor: 11.205

Review 8.  Bacterial Protein Synthesis as a Target for Antibiotic Inhibition.

Authors:  Stefan Arenz; Daniel N Wilson
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

9.  Pipecolic Acid Hydroxylases: A Monophyletic Clade among cis-Selective Bacterial Proline Hydroxylases that Discriminates l-Proline.

Authors:  Johanna Mattay; Wolfgang Hüttel
Journal:  Chembiochem       Date:  2017-06-30       Impact factor: 3.164

10.  A Highly Stereoselective and Scalable Synthesis of L-allo-Enduracididine.

Authors:  William Craig; Janet Chen; David Richardson; Rondel Thorpe; Yu Yuan
Journal:  Org Lett       Date:  2015-09-10       Impact factor: 6.005

View more
  6 in total

1.  Modular Chemoenzymatic Synthesis of GE81112 B1 and Related Analogues Enables Elucidation of Its Key Pharmacophores.

Authors:  Christian R Zwick; Max B Sosa; Hans Renata
Journal:  J Am Chem Soc       Date:  2021-01-08       Impact factor: 15.419

2.  Nature's Machinery, Repurposed: Expanding the Repertoire of Iron-Dependent Oxygenases.

Authors:  Noah P Dunham; Frances H Arnold
Journal:  ACS Catal       Date:  2020-09-28       Impact factor: 13.084

3.  Alternative Reactivity of Leucine 5-Hydroxylase Using an Olefin-Containing Substrate to Construct a Substituted Piperidine Ring.

Authors:  Lide Cha; Sergey Milikisiyants; Madison Davidson; Shan Xue; Tatyana Smirnova; Alex Smirnov; Yisong Guo; Wei-Chen Chang
Journal:  Biochemistry       Date:  2020-05-18       Impact factor: 3.162

4.  Harnessing the biocatalytic potential of iron- and α-ketoglutarate-dependent dioxygenases in natural product total synthesis.

Authors:  Christian R Zwick; Hans Renata
Journal:  Nat Prod Rep       Date:  2020-02-14       Impact factor: 13.423

5.  Engineered and Artificial Metalloenzymes for Selective C-H Functionalization.

Authors:  Xinkun Ren; Rudi Fasan
Journal:  Curr Opin Green Sustain Chem       Date:  2021-04-08

6.  Regiodivergent Biocatalytic Hydroxylation of L-Glutamine Facilitated by Characterization of Non-Heme Dioxygenases from Non-Ribosomal Peptide Biosyntheses.

Authors:  Hans Renata; Emily Shimizu; Christian R Zwick
Journal:  Tetrahedron       Date:  2021-05-08       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.